CN102552987B - 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes - Google Patents

4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes Download PDF

Info

Publication number
CN102552987B
CN102552987B CN201210007812.XA CN201210007812A CN102552987B CN 102552987 B CN102552987 B CN 102552987B CN 201210007812 A CN201210007812 A CN 201210007812A CN 102552987 B CN102552987 B CN 102552987B
Authority
CN
China
Prior art keywords
state
solid
edible
preparation
liquid state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210007812.XA
Other languages
Chinese (zh)
Other versions
CN102552987A (en
Inventor
郁小兵
福原理加
福原由莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yu Xiaobing
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210007812.XA priority Critical patent/CN102552987B/en
Publication of CN102552987A publication Critical patent/CN102552987A/en
Application granted granted Critical
Publication of CN102552987B publication Critical patent/CN102552987B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a kind of 4 DEG C and be in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes, product through edible and medical fungi enzymolysis, cell culture, organize the steps such as enzymolysis to obtain.Can be used as nasolacrimal duct, tumor vessel or deferential transient or permanent occlusion, half blocking material.Manufacture method of the present invention is easy, raw material is easy to get, easy to operate, obtained product is in a liquid state when four degrees celsius, be solid-state when 37 degree, can be used for having tube chamber (as nasolacrimal duct, tumor vessel, deferent duct etc.) in the transient of therapeutic purposes or permanent occlusion, half occluder, can be used as medicine, gene, the slow release platform of vaccine and targetable drug carriers.

Description

4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes
Technical field
The present invention relates to a kind of biological medicine material.
Background technology
Existing medical material is a lot, but also do not have a kind of can in the acceptable temperature range of human body liquid and solid-state between the material of change, therefore the use of a lot of occasion is restricted.
Summary of the invention
A kind of 4 DEG C are the object of the present invention is to provide to be in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes.
Technical solution of the present invention is:
4 DEG C are in a liquid state 37 DEG C in a solid-state biomaterial, and it is characterized in that: be in a liquid state 4 DEG C time, be solid-state 37 DEG C time; Its preparation method is:
(1) edible and medical fungi is carried out enzymolysis processing under the cryogenic conditions of 4-29 DEG C, obtain low temperature edible and medical fungi extracting solution after filtration; Preserve under being placed in 4 DEG C of aseptic conditions;
(2) cell culture: by one or several in fibrocyte, epithelial cell, osteoblast, mixing or single culture; During cell culture, in regular growth culture fluid, add the above-mentioned edible and medical fungi extracting solution of 1-40% percentage by weight, cultivate through 1-12 week, supernatant Collection and conservation is for subsequent use in 4 DEG C of gnotobasiss;
(3) enzyme digestion reaction: fetch and come from bathypelagic fish or mammiferous corium or skeletal tissue; The supernatant above-mentioned tissue and step (2) obtained adds according to 1-12: 1 weight ratio in the enzymolysis solution of 4 DEG C and reacts; Filter under 4 DEG C of gnotobasiss after reaction, filtering accuracy scope: 0.10 μm-0.22 μm; Filtered solution PH is adjusted to 7.4, obtains product, is stored in 4 DEG C of gnotobasiss.
4 DEG C are in a liquid state 37 DEG C in a preparation method for solid-state biomaterial, it is characterized in that: comprise the following steps:
(1) edible and medical fungi is carried out enzymolysis processing under the cryogenic conditions of 4-29 DEG C, obtain low temperature edible and medical fungi extracting solution after filtration; Preserve under being placed in 4 DEG C of aseptic conditions;
(2) cell culture: by one or several in fibrocyte, epithelial cell, osteoblast, mixing or single culture; During cell culture, in regular growth culture fluid, add the above-mentioned edible and medical fungi extracting solution of 1-40% percentage by weight, cultivate through 1-12 week, supernatant Collection and conservation is for subsequent use in 4 DEG C of gnotobasiss;
(3) enzyme digestion reaction: fetch and come from bathypelagic fish or mammiferous corium or skeletal tissue; The supernatant above-mentioned tissue and step (2) obtained adds according to 1-12: 1 weight ratio in the enzymolysis solution of 4 DEG C and reacts; Filter under 4 DEG C of gnotobasiss after reaction, filtering accuracy scope: 0.10 μm-0.22 μm; Filtered solution PH is adjusted to 7.4, obtains product, is stored in 4 DEG C of gnotobasiss.
Described edible and medical fungi is one or several in chanterelle, GANBAJUN, bolete, Termitomyces albuminosus, Morchella esculenta (L.) Pers, Tricholoma lobayense Heim, Pnoliota adiposa(Fr.) Quel., Armillariella mellea, blue or green mushroom, Hericium erinaceus (Bull. Ex Fr.) Pers., red mushroom, Grifola frondosa, Agrocybe aegerita (Brig.) Sing., Ganoderma, Clitocybe maxima, agrocyb eaegerita, pholiota nameko, Mushroom Corals, Oudemansiella Radicata, Pleurotus citrinopileatus, Hypsizygus marmoreus, asafoetida mushroom, Pleurotus eryngii, Pleurotus abalonus, but is not limited only to this.
During the enzymolysis processing of step (1), the enzyme of use is pectase, one or several in cellulase, hemicellulase, α-amylase, glucoamylase, beta amylase; Feed liquid weight ratio: 1: 1-19; The enzyme digestion reaction time: 1-190 hour; PH value: 3-9; Enzyme concentration: be with edible and medical fungi weight ratio: enzyme 0.01-5: edible and medical fungi 100; Filtering accuracy in step (1) is 0.10 μm-0.22 μm.
Enzymatic hydrolysis condition in step (3) is: pH value: 3-5.4; Enzyme digestion reaction temperature: 4-9 degree Celsius; Feed liquid weight ratio: 1: 1-19; The enzyme digestion reaction time: 72-480 hour; The kind of enzyme: one or several in metalloproteases, thiol protease, serine carboxypeptidase, cathepsin, endopeptidase, ficin, pepsin, but be not limited only to this; Enzyme concentration: with raw material weight ratio be: enzyme 0.01-5: raw material 100.
A kind of 4 DEG C of 37 DEG C of application in solid-state biomaterial in preparation in transient or permanent occlusion, half occluder that are in a liquid state.
As nasolacrimal duct, tumor vessel or deferential transient or permanent occlusion, half blocking material.
Manufacture method of the present invention is easy, raw material is easy to get, easy to operate, obtained product is in a liquid state when four degrees celsius, be solid-state when 37 degree, can be used for having tube chamber (as nasolacrimal duct, tumor vessel, deferent duct etc.) in the transient of therapeutic purposes or permanent occlusion, half occluder, can be used as medicine, gene, the slow release platform of vaccine and targetable drug carriers.
Below in conjunction with embodiment, the invention will be further described.
Detailed description of the invention
4 DEG C are in a liquid state 37 DEG C in a preparation method for solid-state biomaterial, comprise the following steps:
(1) edible and medical fungi is carried out enzymolysis processing under the cryogenic conditions of 4-29 DEG C (example 4 DEG C, 15 DEG C, 29 DEG C), obtain low temperature edible and medical fungi extracting solution after filtration; Preserve under being placed in 4 DEG C of aseptic conditions;
(2) cell culture: by one or several in fibrocyte, epithelial cell, osteoblast, mixing or single culture; During cell culture, the above-mentioned edible and medical fungi extracting solution of 1-40% (example 1%, 20%, 40%) percentage by weight is added in regular growth culture fluid, cultivate through 1-12 week (example 1 week, 7 weeks, 12 weeks), supernatant Collection and conservation is for subsequent use in 4 DEG C of gnotobasiss;
(3) enzyme digestion reaction: fetch and come from bathypelagic fish or mammiferous corium or skeletal tissue; The supernatant above-mentioned tissue and step (2) obtained adds in the enzymolysis solution of 4 DEG C according to 1-12: 1 (example 1: 1,6: 1,12: 1) weight ratio and reacts; Filter under 4 DEG C of gnotobasiss after reaction, filtering accuracy scope: 0.10 μm-0.22 μm (example 0.10 μm, 0.18 μm, 0.22 μm); Filtered solution PH is adjusted to 7.4, obtains product, is stored in 4 DEG C of gnotobasiss.
Described edible and medical fungi is one or several in chanterelle, GANBAJUN, bolete, Termitomyces albuminosus, Morchella esculenta (L.) Pers, Tricholoma lobayense Heim, Pnoliota adiposa(Fr.) Quel., Armillariella mellea, blue or green mushroom, Hericium erinaceus (Bull. Ex Fr.) Pers., red mushroom, Grifola frondosa, Agrocybe aegerita (Brig.) Sing., Ganoderma, Clitocybe maxima, agrocyb eaegerita, pholiota nameko, Mushroom Corals, Oudemansiella Radicata, Pleurotus citrinopileatus, Hypsizygus marmoreus, asafoetida mushroom, Pleurotus eryngii, Pleurotus abalonus, but is not limited only to this.
During the enzymolysis processing of step (1), the enzyme of use is pectase, one or several in cellulase, hemicellulase, α-amylase, glucoamylase, beta amylase; Feed liquid weight ratio: 1: 1-19 (example 1: 1,1: 10,1: 19); Enzyme digestion reaction time: 1-190 hour (example 1 hour, 100 hours, 190 hours); PH value: 3-9 (example 3,6,9); Enzyme concentration: be with edible and medical fungi weight ratio: enzyme 0.01-5: edible and medical fungi 100 (example 0.01: 100,3: 100,5: 100); Filtering accuracy in step (1) be 0.10 μm-0.22 μm (example 0.10 μm, 0.18 μm, 0.22 μm).
Enzymatic hydrolysis condition in step (3) is: pH value: 3-5.4 (example 3,4,5); Enzyme digestion reaction temperature: 4-9 degree Celsius (example 4 DEG C, 6 DEG C, 9 DEG C); Feed liquid weight ratio: 1: 1-19 (example 1: 1,1: 10,1: 19); Enzyme digestion reaction time: 72-480 hour (example 72 hours, 200 hours, 480 hours); The kind of enzyme: one or several in metalloproteases, thiol protease, serine carboxypeptidase, cathepsin, endopeptidase, ficin, pepsin, but be not limited only to this; Enzyme concentration: with raw material (namely organizing and supernatant) weight ratio be: enzyme 0.01-5: raw material 100 (example 0.01: 100,3: 100,5: 100).
Above-mentioned 4 DEG C of 37 DEG C of application in solid-state biomaterial in preparation in transient or permanent occlusion, half occluder that are in a liquid state are as nasolacrimal duct, tumor vessel or deferential transient or permanent occlusion, half blocking material.

Claims (7)

1. 4 DEG C are in a liquid state 37 DEG C in a solid-state biomaterial, and it is characterized in that: be in a liquid state 4 DEG C time, be solid-state 37 DEG C time; Its preparation method is:
(1) edible and medical fungi is carried out enzymolysis processing under the cryogenic conditions of 4-29 DEG C, obtain low temperature edible and medical fungi extracting solution after filtration; Preserve under being placed in 4 DEG C of aseptic conditions;
(2) cell culture: by one or several in fibrocyte, epithelial cell, osteoblast, mixing or single culture; During cell culture, in regular growth culture fluid, add the above-mentioned edible and medical fungi extracting solution of 1-40% percentage by weight, cultivate through 1-12 week, supernatant Collection and conservation is for subsequent use in 4 DEG C of gnotobasiss;
(3) enzyme digestion reaction: fetch and come from bathypelagic fish or mammiferous corium or skeletal tissue; The supernatant above-mentioned tissue and step (2) obtained adds according to 1-12: 1 weight ratio in the enzymolysis solution of 4 DEG C and reacts; Filter under 4 DEG C of gnotobasiss after reaction, filtering accuracy scope: 0.10 μm-0.22 μm; Filtered solution PH is adjusted to 7.4, obtains product, is stored in 4 DEG C of gnotobasiss.
2. 4 DEG C according to claim 1 are in a liquid state 37 DEG C in a preparation method for solid-state biomaterial, it is characterized in that: comprise the following steps:
(1) edible and medical fungi is carried out enzymolysis processing under the cryogenic conditions of 4-29 DEG C, obtain low temperature edible and medical fungi extracting solution after filtration; Preserve under being placed in 4 DEG C of aseptic conditions;
(2) cell culture: by one or several in fibrocyte, epithelial cell, osteoblast, mixing or single culture; During cell culture, in regular growth culture fluid, add the above-mentioned edible and medical fungi extracting solution of 1-40% percentage by weight, cultivate through 1-12 week, supernatant Collection and conservation is for subsequent use in 4 DEG C of gnotobasiss;
(3) enzyme digestion reaction: fetch and come from bathypelagic fish or mammiferous corium or skeletal tissue; The supernatant above-mentioned tissue and step (2) obtained adds according to 1-12: 1 weight ratio in the enzymolysis solution of 4 DEG C and reacts; Filter under 4 DEG C of gnotobasiss after reaction, filtering accuracy scope: 0.10 μm-0.22 μm; Filtered solution PH is adjusted to 7.4, obtains product, is stored in 4 DEG C of gnotobasiss.
3. 4 DEG C according to claim 2 are in a liquid state 37 DEG C in the preparation method of solid-state biomaterial, it is characterized in that: described edible and medical fungi is one or several in chanterelle, GANBAJUN, bolete, Termitomyces albuminosus, Morchella esculenta (L.) Pers, Tricholoma lobayense Heim, Pnoliota adiposa(Fr.) Quel., Armillariella mellea, blue or green mushroom, Hericium erinaceus (Bull. Ex Fr.) Pers., red mushroom, Grifola frondosa, Agrocybe aegerita (Brig.) Sing., Ganoderma, Clitocybe maxima, agrocyb eaegerita, pholiota nameko, Mushroom Corals, Oudemansiella Radicata, Pleurotus citrinopileatus, Hypsizygus marmoreus, asafoetida mushroom, Pleurotus eryngii, Pleurotus abalonus.
4. 4 DEG C of 37 DEG C of preparation methoies in solid-state biomaterial that are in a liquid state according to claim 2, it is characterized in that: during the enzymolysis processing of step (1), the enzyme of use is pectase, one or several in cellulase, hemicellulase, α-amylase, glucoamylase, beta amylase; Feed liquid weight ratio: 1: 1-19; The enzyme digestion reaction time: 1-190 hour; PH value: 3-9; Enzyme concentration: be with edible and medical fungi weight ratio: enzyme 0.01-5: edible and medical fungi 100; Filtering accuracy in step (1) is 0.10 μm-0.22 μm.
5. 4 DEG C according to claim 2,3 or 4 are in a liquid state 37 DEG C in the preparation method of solid-state biomaterial, it is characterized in that: the enzymatic hydrolysis condition in step (3) is: pH value: 3-5.4; Enzyme digestion reaction temperature: 4-9 degree Celsius; Feed liquid weight ratio: 1: 1-19; The enzyme digestion reaction time: 72-480 hour; The kind of enzyme: one or several in metalloproteases, thiol protease, serine carboxypeptidase, cathepsin, endopeptidase, ficin, pepsin; Enzyme concentration: with raw material weight ratio be: enzyme 0.01-5: raw material 100.
6. 4 DEG C of 37 DEG C of application in solid-state biomaterial in preparation in transient or permanent occlusion, half occluder that are in a liquid state according to claim 1.
7. 4 DEG C of 37 DEG C of application in solid-state biomaterial in preparation in transient or permanent occlusion, half occluder that are in a liquid state according to claim 6, is characterized in that: be as nasolacrimal duct, tumor vessel or deferential transient or permanent occlusion, half blocking material.
CN201210007812.XA 2012-01-12 2012-01-12 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes Active CN102552987B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210007812.XA CN102552987B (en) 2012-01-12 2012-01-12 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210007812.XA CN102552987B (en) 2012-01-12 2012-01-12 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes

Publications (2)

Publication Number Publication Date
CN102552987A CN102552987A (en) 2012-07-11
CN102552987B true CN102552987B (en) 2016-01-06

Family

ID=46400433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210007812.XA Active CN102552987B (en) 2012-01-12 2012-01-12 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes

Country Status (1)

Country Link
CN (1) CN102552987B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110755627A (en) * 2019-12-02 2020-02-07 北京福原科技有限公司 Temperature-sensitive drug delivery material in liquid state at 4 ℃ and solid state at 37 DEG C

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1709915A (en) * 2005-06-23 2005-12-21 南京大学医学院附属鼓楼医院 Polysaccharide material for promoting cell tactophily and preparation thereof
CN101921821A (en) * 2010-08-06 2010-12-22 郁小兵 Method for extracting high-quality collagen at low temperature
CN101947245A (en) * 2010-08-27 2011-01-19 郁小兵 Method for extracting effective components of edible and medical fungi in ordinary state

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028936A (en) * 1983-07-27 1985-02-14 Koken:Kk Atherocollagen aqueous solution and its preparation
US5648208A (en) * 1991-08-01 1997-07-15 Coletica Use of a collagen as solid binding substrate for a ligand capable of reacting specifically with an element to be detected in a biological medium, reactant and implementation
CN101869263A (en) * 2010-05-27 2010-10-27 郁小兵 Edible fungi dietary fiber and production method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1709915A (en) * 2005-06-23 2005-12-21 南京大学医学院附属鼓楼医院 Polysaccharide material for promoting cell tactophily and preparation thereof
CN101921821A (en) * 2010-08-06 2010-12-22 郁小兵 Method for extracting high-quality collagen at low temperature
CN101947245A (en) * 2010-08-27 2011-01-19 郁小兵 Method for extracting effective components of edible and medical fungi in ordinary state

Also Published As

Publication number Publication date
CN102552987A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
CN101015379B (en) Process for preparing agaricus blazei healht-care liquid
CN103651151A (en) Fungus for promoting aquilaria plants to generate agilawood and application of fungus
CN103952451B (en) Adopt Radix Astragali extractive solution to improve the method for hickory chick submerged fermentation mycelium polysaccharides content
CN107409742B (en) Artificial culture method of cordyceps sobolifera
CN103740595A (en) Method for producing chlorella concentrated solution
CN102552987B (en) 4 DEG C are in a liquid state 37 DEG C in solid-state biomaterial and preparation method with purposes
CN110004065B (en) Novel Ganoderma lucidum strain and artificial cultivation method and application thereof
Bilay et al. Growth of edible and medicinal mushrooms on commercial agar media
CN110408724A (en) The primer and molecule labelling method of the molecular labeling of fragrant Na needle mushroom new strains
CN102174417A (en) Cordyceps sinensis mycelium solid fermentation extract and application thereof to preparing anti-fatigue product
CN108064793A (en) A kind of facility cultivating system and method using diatom prevention and control shrimp disease
Amoozegar et al. A preliminary study on domestication of wild-growing medicinal mushrooms collected from Northern Iran
CN103704022A (en) Method for cultivating artificial cordyceps sinensis with five-instar silkworms as carrier
WO2021047031A1 (en) Novel flammulina fennae strain as well as molecular marker primer and molecular marking method thereof
CN106358762A (en) Culture method for breeding antrodia camphorate by cinnamomum micranthum instead of antrodia camphorata
CN103843580A (en) Paecilomyces hepialid mycelium and preparation method thereof
CN102498947A (en) Method for culturing cordyceps sinensis by performing endogenous pressurization and artificial infection of hirsutella sinensis on hepialus larvae
CN104221703B (en) Composition at the bottom of Antrodia camphorata thalline cultural method and culture medium
CN102229507B (en) Cordyceps militaris water culturing medium
CN104830665A (en) Method and special device for cultivating spirulina
CN101947245A (en) Method for extracting effective components of edible and medical fungi in ordinary state
CN104351613A (en) Fungus polysaccharide and preparation process thereof
CN103749149A (en) Method for cultivating artificial worm grass with mealworm pupa as carrier
CN103667062A (en) Protective agent for low-temperature preservation of asexual spores of antrodia cinnamomea and protective agent using method
TW201439317A (en) Taiwanofungus camphoratus fungus culturing method and culturing substrate ingredient

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Yu Xiaobing

Inventor after: Fukuhara Management

Inventor after: Fukuhara Yuri

Inventor before: Fukuhara Management

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20151124

Address after: 100000 Beijing city Chaoyang District Liulitun Building No. 1 2006

Applicant after: Yu Xiaobing

Address before: 100000 Beijing Chaoyang District solidarity Hubei headlines 14-2-403

Applicant before: Fukuhara Management

C14 Grant of patent or utility model
GR01 Patent grant